Electrophysiological Mechanisms and Inhibitory Cardiac Syncope

ELectrophysiological Mechanisms Underlying the Inhibitory CArdiac Syncope: Therapeutic and Prognostic Implications The ELICA Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02861274

Acronym

ELICA

Enrollment

Registered

2016-08-10

Start date

2010-01-31

Completion date

2015-09-30

Last updated

2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Syncope Recurrent

Brief summary

OBJECTIVES: To evaluate syncope recurrence at follow up in patients with a positive cardio inhibitory response to the head up tilt testing (HUT) evaluation. METHODS: 36 consecutive patients affected by cardio inhibitory syncope to HUT without asystolia (2A type) have been enrolled in this study. These patients have been studied by electrophysiological study (ES). After ES patients have been differently treated (interventional treatment group A, v/s drug therapy group), and followed up during 360 days, to evaluate syncope recurrences.

Interventions

DEVICEpacemaker

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age more than 18, normal heart function, more than 1 syncope event for year.

Exclusion criteria

* age inferior 18 years, history of myocardial infarction, heart failure, structural heart disease.

Design outcomes

Primary

Measure	Time frame
syncope recurrence	360 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026